Literature DB >> 8964846

The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.

S L Asa1, A M Bamberger, B Cao, M Wong, K L Parker, S Ezzat.   

Abstract

Steroidogenic factor-1 (SF-1), also known as adrenal-4-binding protein, is a transcription factor that is important for the differentiation of steroidogenic tissues. We investigated whether SF-1 is expressed in specific hormone-producing cell types in the human pituitary and its adenomas. Pituitary adenomas (n = 35) were collected at the time of surgery, and normal adenohypophyses were obtained from autopsies; 3 corticotroph adenomas were excluded because pit-1 messenger ribonucleic acid (mRNA) expression indicated contamination by nontumorous elements. Expression of SF-1 mRNA was determined by reverse transcription-PCR. SF-1 protein was localized with immunocytochemistry. By reverse transcription-PCR, SF-1 mRNA was found in the nontumorous pituitary and in pituitary adenomas expressing gonadotropins. All 8 gonadotroph adenomas had a strong signal for SF-1. SF-1 mRNA was also detected in 2 of 3 corticotroph adenomas, 2 of 13 somatotroph/mammosomatotroph adenomas, 1 of 6 lactotroph adenomas, and 2 silent subtype 3 adenomas; however, in most of the positive tumors there was also positivity for FSH beta and/or LH beta mRNA, suggesting that contaminating nontumorous gonadotrophs may be the source of SF-1 mRNA signal. SF-1 protein was localized by immunocytochemistry in the nuclei of scattered cells of the nontumorous adenohypophysis that were shown to be gonadotrophs with double immunostaining and in gonadotroph adenomas; nuclear staining was not found in other adenoma types, except in areas shown to contain trapped nontumorous tissue. We conclude that SF-1 expression correlates with the expression of gonadotropins. These findings implicate SF-1 as a cell-specific transcription factor that may regulate gonadotroph differentiation in the pituitary.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964846     DOI: 10.1210/jcem.81.6.8964846

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

1.  Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation.

Authors:  R A Jastania; K O Alsaad; M Al-Shraim; K Kovacs; S L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Activation of the rat follicle-stimulating hormone receptor promoter by steroidogenic factor 1 is blocked by protein kinase a and requires upstream stimulatory factor binding to a proximal E box element.

Authors:  L L Heckert
Journal:  Mol Endocrinol       Date:  2001-05

Review 3.  Advances and controversies in the classification and grading of pituitary tumors.

Authors:  E R Laws; D L Penn; C S Repetti
Journal:  J Endocrinol Invest       Date:  2018-06-01       Impact factor: 4.256

4.  [The 2017 WHO classification of pituitary tumors].

Authors:  Wolfgang Saeger
Journal:  Pathologe       Date:  2021-04-20       Impact factor: 1.011

Review 5.  Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

Authors:  Odelia Cooper; Shlomo Melmed
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

6.  Expression of steroidogenic factor 1 in the testis requires an E box and CCAAT box in its promoter proximal region.

Authors:  M A Daggett; D A Rice; L L Heckert
Journal:  Biol Reprod       Date:  2000-03       Impact factor: 4.285

Review 7.  Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas.

Authors:  Mansur E Shomali; Laurence Katznelson
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

8.  Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.

Authors:  Henriett Butz; Kinga Németh; Dóra Czenke; István Likó; Sándor Czirják; Vladimir Zivkovic; Kornélia Baghy; Márta Korbonits; Ilona Kovalszky; Péter Igaz; Károly Rácz; Attila Patócs
Journal:  Pathol Oncol Res       Date:  2016-12-21       Impact factor: 3.201

9.  Expression of Pit-1 and growth hormone-releasing hormone receptor mRNA in human pituitary adenomas: difference among functioning, silent, and other nonfunctioning adenomas.

Authors:  Ikuo Kobayashi; Hidehiro Oka; Heiji Naritaka; Yuichi Sato; Kiyotaka Fujii; Toru Kameya
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

10.  Effects of ovariectomy and hypothalamic-pituitary disconnection on amounts of steroidogenic factor-1 mRNA in the ovine anterior pituitary gland.

Authors:  A M Turzillo; C C Quirk; J L Juengel; T M Nett; C M Clay
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.